Literature DB >> 15741286

Measures of physical performance and risk for progressive and catastrophic disability: results from the Women's Health and Aging Study.

Graziano Onder1, Brenda W J H Penninx, Luigi Ferrucci, Linda P Fried, Jack M Guralnik, Marco Pahor.   

Abstract

BACKGROUND: Physical performance measures can predict incident disability, but little research has assessed and compared how these measures predict progressive and rapid-onset (catastrophic) disability. The authors evaluated the ability of upper and lower extremity performance measures to predict progressive and catastrophic disability in activities of daily living (ADL), mobility, and upper extremity function.
METHODS: The incidence of progressive and catastrophic disability was assessed semiannually during a 3-year period in 884 women participating in the Women's Health and Aging Study I. Four-meter walking speed, balance, and chair stands tests were used to evaluate lower extremity function. The putting-on-blouse test, the Purdue pegboard test, and grip strength were used to assess upper extremity function. Summary performance scores (SPS) for the lower and upper extremities were calculated. Among participants in whom disability developed, those who reported no difficulty in the previous year were defined as cases of catastrophic disability, and those who previously reported little or some difficulty were considered to be cases of progressive disability. Cox proportional hazard regression analyses were used to evaluate the association of performance measures and time to incident disability. The predictive ability of performance measures was compared using receiver-operator characteristic curves.
RESULTS: All lower and upper extremity measures, with the exception of grip strength, significantly predicted the onset of progressive ADL disability, but only walking speed was significantly associated with the onset of catastrophic ADL disability. The chair stands test, walking speed, and the lower extremity SPS were significantly associated with the onset of both progressive and catastrophic mobility disability. Only lower extremity individual tests and SPS significantly predicted the onset of both progressive and catastrophic upper extremity disability. The receiver-operator characteristic curves for ADL and mobility disability showed that all performance measures evaluated had a greater predictive ability for progressive than for catastrophic incident disability. This finding was not consistent for upper extremity disability. The areas under the curve for walking speed and lower extremity SPS were very similar, ranging from 0.58 to 0.81 and from 0.57 to 0.85, and the predictive ability of these two measures was the greatest for all disability outcomes assessed.
CONCLUSION: Physical performance measures of lower extremity and, in particular, walking speed and lower extremity SPS are valuable tools to predict different forms of disability, especially those with a progressive onset.

Entities:  

Mesh:

Year:  2005        PMID: 15741286     DOI: 10.1093/gerona/60.1.74

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  123 in total

1.  Effect of new disability subtype on 3-year mortality in Chinese older adults.

Authors:  Qiushi Feng; Helen M Hoenig; Danan Gu; Zeng Yi; Jama L Purser
Journal:  J Am Geriatr Soc       Date:  2010-10       Impact factor: 5.562

2.  A randomized controlled trial of an activity specific exercise program for individuals with Alzheimer disease in long-term care settings.

Authors:  Kathryn E Roach; Ruth M Tappen; Neva Kirk-Sanchez; Christine L Williams; David Loewenstein
Journal:  J Geriatr Phys Ther       Date:  2011 Apr-Jun       Impact factor: 3.381

3.  Physical activity and functional limitations in older adults: the influence of self-efficacy and functional performance.

Authors:  Sean P Mullen; Edward McAuley; William A Satariano; Melissa Kealey; Thomas R Prohaska
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2012-04-03       Impact factor: 4.077

4.  Outcome measures in cardiopulmonary physical therapy: short physical performance battery.

Authors:  Michael L Puthoff
Journal:  Cardiopulm Phys Ther J       Date:  2008-03

5.  Socio-economic disadvantage from childhood to adulthood and locomotor function in old age: a lifecourse analysis of the Boyd Orr and Caerphilly prospective studies.

Authors:  Kate Birnie; Richard M Martin; John Gallacher; Antony Bayer; David Gunnell; Shah Ebrahim; Yoav Ben-Shlomo
Journal:  J Epidemiol Community Health       Date:  2010-07-19       Impact factor: 3.710

6.  The recursive effects of quality of life and functional limitation among older adult cancer patients: evidence from the Survey of Health, Ageing and Retirement in Europe.

Authors:  Y Hamama-Raz; A Shrira; M Ben-Ezra; Y Palgi
Journal:  Eur J Cancer Care (Engl)       Date:  2015-02-09       Impact factor: 2.520

7.  Changes in physical performance in older women according to presence and treatment of diabetes mellitus.

Authors:  Christine G Lee; Ann V Schwartz; Kristine Yaffe; Teresa A Hillier; Erin S LeBlanc; Peggy M Cawthon
Journal:  J Am Geriatr Soc       Date:  2013-10-28       Impact factor: 5.562

8.  Management of Dementia and Depression Utilizing In- Home Passive Sensor Data.

Authors:  Colleen Galambos; Marjorie Skubic; Shaung Wang; Marilyn Rantz
Journal:  Gerontechnology       Date:  2013-01-01

9.  Relationship of physical function to vastus lateralis capillary density and metabolic enzyme activity in elderly men and women.

Authors:  Barbara J Nicklas; Iris Leng; Osvaldo Delbono; Dalane W Kitzman; Anthony P Marsh; W Gregory Hundley; Mary F Lyles; Kenneth S O'Rourke; Brian H Annex; William E Kraus
Journal:  Aging Clin Exp Res       Date:  2008-08       Impact factor: 3.636

10.  Association between chair stand strategy and mobility limitations in older adults with symptomatic knee osteoarthritis.

Authors:  Neil A Segal; Elizabeth R Boyer; Robert Wallace; James C Torner; H John Yack
Journal:  Arch Phys Med Rehabil       Date:  2012-10-09       Impact factor: 3.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.